Group One Trading
IRD

Group One Trading’s Opus Genetics IRD Stock Holding History

Group One Trading’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.7K Sell
12,100
-37,000
-75% -$173K ﹤0.01% 5407
2026
Q1 		$223K Buy
49,100
+5,600
+13% +$19.4K ﹤0.01% 4024
2025
Q4 		$87.4K Buy
43,500
+43,000
+8,600% +$87.3K ﹤0.01% 5114
2025
Q3 		$825 Sell
500
-1,400
-74% -$1.74K ﹤0.01% 8088
2025
Q2 		$1.79K Hold
1,900
– – ﹤0.01% 7441
2025
Q1 		$1.86K Sell
1,900
-1,600
-46% -$1.79K ﹤0.01% 7019
2024
Q4 		$4.17K Buy
+3,500
New +$4.02K ﹤0.01% 6489
2024
Q2 		– Sell
-104,100
Closed -$209K – 7628
2024
Q1 		$209K Sell
104,100
-600
-0.6% -$1.52K ﹤0.01% 3524
2023
Q4 		$315K Buy
104,700
+104,100
+17,350% +$308K ﹤0.01% 3469
2023
Q3 		$2.01K Sell
600
-22,300
-97% -$89.5K ﹤0.01% 7040
2023
Q2 		$99.4K Buy
22,900
+21,600
+1,662% +$103K ﹤0.01% 4624
2023
Q1 		$4.88K Sell
1,300
-3,500
-73% -$12.6K ﹤0.01% 6290
2022
Q4 		$16.9K Sell
4,800
-54,800
-92% -$144K ﹤0.01% 5701
2022
Q3 		$120K Sell
59,600
-45,600
-43% -$98.4K ﹤0.01% 4606
2022
Q2 		$202K Buy
105,200
+78,900
+300% +$179K ﹤0.01% 4300
2022
Q1 		$85K Sell
26,300
-29,100
-53% -$99.6K ﹤0.01% 5654
2021
Q4 		$207K Buy
55,400
+20,000
+56% +$80.2K ﹤0.01% 5058
2021
Q3 		$182K Buy
35,400
+31,600
+832% +$146K ﹤0.01% 5274
2021
Q2 		$20K Buy
+3,800
New +$18.9K ﹤0.01% 7197
2019
Q1 		– Sell
-158
Closed -$7K – 5464
2018
Q4 		$7K Hold
158
– – ﹤0.01% 4401
2018
Q3 		$14K Sell
158
-217
-58% -$16.8K ﹤0.01% 4545
2018
Q2 		$25K Buy
375
+167
+80% +$14.7K ﹤0.01% 4291
2018
Q1 		$15K Sell
208
-365
-64% -$33.1K ﹤0.01% 4191
2017
Q4 		$56K Sell
573
-108
-16% -$11K ﹤0.01% 3672
2017
Q3 		$79K Buy
681
+56
+9% +$6.04K ﹤0.01% 3380
2017
Q2 		$86K Buy
+625
New +$122K ﹤0.01% 3201

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Group One Trading's IRD Position: Q2 2026 in Review

Group One Trading sold out of Opus Genetics (IRD) in Q2 2026, closing a stake of 10,594 shares — an estimated $49.4K sold.

Group One Trading first reported a position in IRD in Q3 2017 and held it in 12 quarters. The position peaked at $163K in Q3 2021. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Group One Trading reported no remaining Opus Genetics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 10,594 Opus Genetics shares in Q2 2026, an estimated $49.4K.
  • Group One Trading first reported a position in Opus Genetics in Q3 2017 and held it in 12 quarters.
  • Group One Trading's Opus Genetics position peaked at $163K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.